HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


European Trade Groups To Cosmetics Firms: Be Prepared For ‘No Deal’ Brexit

This article was originally published in The Rose Sheet

Executive Summary

The UK is converting the EU’s Cosmetics Regulation and REACH into UK law, holding out hope that mutual interests will yield an arrangement for “frictionless trade.” However, the Cosmetic, Toiletry and Perfumery Association notes “the political landscape is very uncertain.”

You may also be interested in...

UK eyes FDA if no EMA deal

If the UK fails to secure full regulatory alignment with the European Union (EU) on medicines as part of negotiations over its ‘Brexit’ withdrawal from the EU, then the country may seek to align with the USFood and Drug Administration (FDA),according to a UK House of Commons health and social care committee report on the impact of Brexit on medicines.

Wishful Thinking? UK Trade Group Outlines Brexit Priorities For Cosmetics

Developed in partnership with its members, the UK-based Cosmetic, Toiletry and Perfumery Association’s position paper on Brexit implications seeks negotiated terms that would ensure minimal business disruption for industry. However, one of its priorities – to remain in the EU Customs Union – already is in serious doubt, with UK leadership angling for a “hard exit” from the bloc.

US And Trading Neighbors Advocate Risk-Based, Science-Backed Cosmetics Regs

As European industry’s concerns grow about “politicization” of regulatory programs, the United States-Mexico-Canada Agreement’s cosmetics annex directs regulatory authorities pursuing new rules to give due consideration to scientific and technical guidance documents developed through international collaboration.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts